Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancerMyrto Moutafi, David L. Rimm, Yalai Bai et al.|Laboratory Investigation|2022Cited by 141
Multi-Institutional Study of Pathologist Reading of the Programmed Cell Death Ligand-1 Combined Positive Score Immunohistochemistry Assay for Gastric or Gastroesophageal Junction CancerAileen I. Fernandez, David L. Rimm, Charles T. Robbins et al.|Modern Pathology|2023Cited by 26
Tissue Age Affects Antigenicity and Scoring for the 22C3 Immunohistochemistry Companion Diagnostic TestAileen I. Fernandez, David L. Rimm, Patricia Gaule|Modern Pathology|2023Cited by 18